Literature DB >> 8102718

The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori.

T Hussell1, P G Isaacson, J E Crabtree, J Spencer.   

Abstract

An association has been shown between colonisation of gastric mucosa by Helicobacter pylori, acquisition of mucosa-associated lymphoid tissue (MALT), and occurrence of primary B-cell gastric MALT lymphoma. We investigated the immunological response of cells from 3 low-grade primary B-cell gastric MALT lymphomas to H pylori type NCTC 11637 and 12 isolates of H pylori from patients without lymphomas. After co-culture of tumour cells with bacteria, cells were examined for phenotypic evidence of activation and proliferation, and supernatant assayed to detect tumour-derived immunoglobulin and interleukin-2 (IL-2). Neoplastic B cells and non-neoplastic T cells proliferated, and IL-2-receptor expression by most cells in the cultures was increased with stimulating strains of H pylori. There were also increases in tumour immunoglobulin and IL-2 release when activation and proliferation were seen in response to stimulating bacteria. Removal of T cells from the tumour cell suspension reduced proliferation and IL-2-receptor expression. In comparison, no responses were seen in cells from high-grade gastric MALT lymphomas or low-grade B-cell MALT lymphomas of other sites. The response of low-grade B-cell gastric MALT lymphomas to stimulating strains of H pylori is dependent on H-pylori-specific T cells and their products, rather than the bacteria themselves.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8102718     DOI: 10.1016/0140-6736(93)91408-e

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  155 in total

Review 1.  Presentation and management of Helicobacter pylori infection in childhood.

Authors:  U Blecker; N K Mittal; D I Mehta
Journal:  Indian J Pediatr       Date:  1996 May-Jun       Impact factor: 1.967

2.  Superantigens and autoantigens may be involved in the pathogenesis of gastric mucosa-associated lymphoid tissue lymphoma.

Authors:  T Hashimoto; M Takishita; M Kosaka; T Sano; T Matsumoto
Journal:  Int J Hematol       Date:  2001-08       Impact factor: 2.490

Review 3.  Ectopic lymphoid organogenesis: a fast track for autoimmunity.

Authors:  C M Weyand; P J Kurtin; J J Goronzy
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

4.  Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low.

Authors:  R J Farrell; Y Ang; P Kileen; D S O'Briain; D Kelleher; P W Keeling; D G Weir
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

5.  Molecular characterization of a flagellar export locus of Helicobacter pylori.

Authors:  S Porwollik; B Noonan; P W O'Toole
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

6.  Low-grade B cell lymphomas of mucosa-associated lymphoid tissue (MALT-type) require CD40-mediated signaling and Th2-type cytokines for in vitro growth and differentiation.

Authors:  A Greiner; C Knörr; Y Qin; W Sebald; A Schimpl; J Banchereau; H K Müller-Hermelink
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

7.  Regression of atypical lymphoid hyperplasia after eradication of Helicobacter pylori.

Authors:  T Tanahashi; Y Tatsumi; N Sawai; Y Yamaoka; M Nakajima; T Kodama; K Kashima
Journal:  J Gastroenterol       Date:  1997-08       Impact factor: 7.527

8.  Lymphocytic gastritis, gastric adenocarcinoma, and primary gastric lymphoma.

Authors:  A P Griffiths; J Wyatt; A S Jack; M F Dixon
Journal:  J Clin Pathol       Date:  1994-12       Impact factor: 3.411

9.  Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series.

Authors:  W Fischbach; M-E Goebeler-Kolve; B Dragosics; A Greiner; M Stolte
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

10.  In vitro binding of Helicobacter pylori to monohexosylceramides.

Authors:  M Abul-Milh; D Barnett Foster; C A Lingwood
Journal:  Glycoconj J       Date:  2001-03       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.